Introduction {#sec1}
============

In recent years, DNA-encoded chemical libraries (DECLs) have emerged as a powerful hit generation tool for discovery campaigns.^[@ref1]−[@ref5]^ DECLs are large collections of small molecules covalently tagged with a unique DNA sequence which enables multiplexed affinity- or activity-based screens of libraries against biological targets with subsequent decoding by high-throughput DNA sequencing.^[@ref6],[@ref7]^ Although many forms of the underlying DNA-tag concept have been reported,^[@ref8]−[@ref18]^ the solution-phase DNA-recorded synthesis variant has proven to be a versatile platform for affinity-based screens as library compounds may be built directly with inventory chemical building blocks,^[@ref19]^ expensive large-scale synthetic DNA stocks may be reused between DECLs,^[@ref9]^ novel million-member DECLs can routinely be produced at scales for thousands of screens, and affinity-based target screens of billions of compounds may be performed, sequenced and analyzed in as little as 2 weeks.^[@ref20]^ However, although there are robust methods for the manipulation of the encoding DNA tags,^[@ref21]^ only a limited set of chemical transformations have been reported for DECL small molecule synthesis.^[@ref22]−[@ref35]^ DECL DNA-chemical conjugates generally require partially aqueous media to remain in solution, and DNA is sensitive to some conditions (e.g., strong acids, high temperatures, oxidants);^[@ref25]^ thus, adaptation of common synthetic transformations and bond-disconnect strategies to DNA-compatible processes is needed to further expand DECL small molecule chemical space.

Palladium-catalyzed C--N coupling holds a prominent place in the chemist's toolbox as a widely used reaction in fine chemical synthesis and medicinal chemistry efforts.^[@ref36],[@ref37]^ In particular, the palladium-catalyzed C--N coupling of (hetero)aromatic or aliphatic amines with (hetero)aromatic electrophiles has been utilized in the creation of screening compound collections,^[@ref38]^ for diversification of hit series in structure--activity studies,^[@ref39]^ and as a synthetic disconnect in large-scale pharmaceutical productions.^[@ref40]^ C--N coupling is particularly useful in combinatorial approaches as very large and diverse collections of multifunctional (hetero)aryl electrophiles and amino nucleophiles are commercially available.^[@ref38]^ This, along with the advent of specialized phosphine ligands for palladium-catalyzed C--N coupling^[@ref41],[@ref42]^ and innovations in the rapid generation of active palladium species,^[@ref43],[@ref44]^ has spurred development of a variety of mild C--N coupling conditions, including in water or aqueous solvent mixtures.^[@ref45]^ However, extension of metal-catalyzed C--N coupling to solution-phase DECL synthesis is challenging as not only must it be applicable for thousands to millions of sterically and electronically distinct substrate pairs but also working in multiwell plate format in the presence of DNA and water introduces additional challenges: (a) ready decomposition of catalysts from aerobic or aqueous decomposition pathways; (b) palladium- or heat-promoted degradation of DNA or molecular linkages particularly in the case of prolonged reaction times; (c) a basicity limit in the system due to the presence of water; (d) dehalogenation pathways arising from palladium species produced from water or β-hydride transfer; (e) poor catalyst solubility in aqueous--organic mixtures.

Despite these challenges, several groups have reported procedures for metal-catalyzed C--N coupling on DNA--chemical conjugates for DECL applications: (1) Lu et al. disclosed the palladium-catalyzed coupling of different aromatic amines and a copper-catalyzed coupling of aliphatic amines on a *p*-iodobenzamide substrate;^[@ref46]^ (2) Ruff et al. reported a copper-catalyzed system for Ullmann-type couplings of a variety of primary and secondary aliphatic amines with different (hetero)aromatic iodides;^[@ref47]^ (3) de Pedro Beato et al. described a palladium-catalyzed method for the coupling of different (hetero)aryl bromides with aromatic amines;^[@ref48]^ (4) Flood et al. published a solid-phase nickel-catalyzed electrochemical amination of aliphatic and aromatic amines on a *p*-iodobenzamide substrate ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A).^[@ref49]^ These conditions were demonstrated on iodide and bromide electrophiles; however, many halogenated building blocks from commercial or historical collections may only be readily available in brominated or chlorinated form, limiting the input DECL building block diversity. Having previously utilized C--N coupling successfully within several internal DECL productions,^[@ref26]^ we sought to develop alternate solution-phase palladium-catalyzed conditions that might couple a variety of (hetero)aryl bromides and chlorides with aromatic amines and if possible select aliphatic amine nucleophiles ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}B). In addition, we sought to validate these conditions through a wide study of coupling partners and functional group tolerance, investigation on substrates with library-relevant DNA tags, and demonstration within a DECL build with DNA sequencing analysis for ultimate application in target-based "selection"^[@ref50]^ campaigns.

![Metal-Catalyzed C--N Coupling](bc9b00863_0004){#sch1}

Results and Discussion {#sec2}
======================

We began our studies by investigating previously disclosed palladium-based conditions^[@ref46],[@ref48]^ on the coupling of 17-bp dsDNA-linked, methoxy-substituted aryl bromide **1** with aniline ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}; see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00863/suppl_file/bc9b00863_si_001.pdf) for full structural information on conjugate). Although the conditions from Lu et al. could produce **1a** in good yield (entry 1, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), DNA decomposition was detected due to the harsh reaction conditions (hydroxide base for 3 h at 100 °C). Application of the system from de Pedro Beato et al.^[@ref48]^ or from a recent DECL synthesis we reported^[@ref26]^ provided the coupled product in poor conversions (entries 2 and 3, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), and attempts to further optimize BrettPhos Pd G3 were not successful (e.g., entries 4 and 5, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). PEPPSI (pyridine-enhanced precatalyst preparation stabilization and initiation) catalysts are a series of stable Pd(+2) complexes that include a *N*-heterocylic carbene (NHC) ligand and a fast-dissociating pyridyl ligand and have been widely used in palladium-catalyzed cross-coupling.^[@ref51]−[@ref53]^ Although use of Pd-PEPPSI-*i*Pent^Cl^ with 1-methoxy-2-isopropanol cosolvent failed to provide **1a**, upon switching to dimethylacetamide cosolvent a very modest amount of product was observed (entries 6 and 7, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}; see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} for catalyst structure). Hypothesizing that the low conversion could stem from inefficient formation of the active palladium species, we were pleased to observe fair conversions to **1a** when sodium ascorbate was included as a reducing agent/oxygen scavenger (entries 8 and 9, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref47]^ Encouraged by this result, we began a screen of reaction parameters with the PEPPSI-*i*Pent^Cl^ catalyst ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). From this initial condition, increasing the amount of catalyst loading or equivalents of sodium ascorbate used had no beneficial effect (entries 1--3, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), whereas lowering the amount of catalyst hurt the conversion (entries 4--6, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

###### General Screening of Palladium Catalyst Systems

![](bc9b00863_0006){#GRAPHIC-d7e435-autogenerated}

  entry                               catalyst   base   time            solvent   additive       conversion[a](#t1fn1){ref-type="table-fn"}
  ----------------------------------- ---------- ------ --------------- --------- -------------- --------------------------------------------
  1[b](#t1fn2){ref-type="table-fn"}   A          CsOH   100 °C, 3 h     DMA       N/A            75%
  2[c](#t1fn3){ref-type="table-fn"}   B          NaOH   60 °C, 2 h      DMA       N/A            30%
  3[d](#t1fn4){ref-type="table-fn"}   C          CsOH   95 °C, 25 min   MIPO      N/A            33%
  4[e](#t1fn5){ref-type="table-fn"}   C          CsOH   95 °C, 25 min   MIPO      N/A            0%
  5[e](#t1fn5){ref-type="table-fn"}   C          CsOH   95 °C, 25 min   DMA       N/A            6%
  6[f](#t1fn6){ref-type="table-fn"}   D          CsOH   95 °C, 25 min   MIPO      N/A            0%
  7[f](#t1fn6){ref-type="table-fn"}   D          CsOH   95 °C,25 min    DMA       N/A            14%
  8[g](#t1fn7){ref-type="table-fn"}   D          CsOH   95 °C, 25 min   DMA       Na ascorbate   57%
  9[g](#t1fn7){ref-type="table-fn"}   D          CsOH   95 °C, 15 min   DMA       Na ascorbate   63%

The conversion was determined by LC-MS.

Condition reported by GSK^[@ref46]^.

Condition reported by Eli Lilly^[@ref48]^.

Condition reported by BCM^[@ref26]^.

Reaction conditions: **1** (5 nmol), 250 equiv of aniline (400 mM), 2 equiv of catalyst (5 mM), 500 equiv of CsOH (1000 mM), H~2~O (2.5 μL), solvent (4.9 μL).

Reaction conditions: **1** (5 nmol), 250 equiv of aniline (400 mM), 2 equiv of catalyst (5 mM), 500 equiv of CsOH (1000 mM), H~2~O (2.5 μL), solvent (4.9 μL).

Reaction conditions: **1** (5 nmol), 250 equiv of aniline (400 mM), 2 equiv of catalyst (5 mM), 500 equiv of CsOH (1000 mM), 20 equiv of sodium ascorbate (40 mM), DMA (4.9 μL). DMA = dimethylacetamide. MIPO = 1-methoxy-2-isopropanol.

###### Optimization of Parameters

![](bc9b00863_0007){#GRAPHIC-d7e722-autogenerated}

  entry                                aniline (equiv)   Pd (equiv)   ascorbate (equiv)   base (equiv)          conversion[a](#t2fn1){ref-type="table-fn"}
  ------------------------------------ ----------------- ------------ ------------------- --------------------- --------------------------------------------
  1                                    250               2            20                  CsOH (500)            63%
  2                                    250               2            40                  CsOH (500)            63%
  3                                    250               5            50                  CsOH (500)            59%
  4                                    250               1            5                   CsOH (500)            0%
  5                                    250               1            10                  CsOH (500)            20%
  6                                    250               1            20                  CsOH (500)            53%
  7                                    250               2            20                  Cs~2~CO~3~ (500)      32%
  8                                    250               2            20                  pH 9.5 Borate (500)   0%
  9[b](#t2fn2){ref-type="table-fn"}    250               2            20                  CsOH (500)            0%
  10[c](#t2fn3){ref-type="table-fn"}   250               2            20                  CsOH (500)            63%
  11[d](#t2fn4){ref-type="table-fn"}   250               2            20                  CsOH (500)            56%
  12[e](#t2fn5){ref-type="table-fn"}   250               2            20                  CsOH (500)            0%
  13                                   250               2            20                  CsOH (750)            66%
  14                                   250               2            20                  CsOH (1000)           67%
  **15**                               **500**           **2**        **20**              **CsOH (1000)**       **80%**

The conversion was determined by LC-MS.

The condition was carried out at 80 °C.

The reaction was run for 5 min.

The reaction was run for 60 min.

The reaction concentration was 0.05 mM.

Attempts to use weaker bases such as carbonate or borate (e.g., entries 7 and 8, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) led to lower conversion. No coupling was observed when the reaction was run at 80 °C, similar conversions were observed for 5 and 60 min reaction times, and the reaction was sensitive to further dilution (entries 8--11, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). However, upon increasing the amounts of building block and base, boosts in conversion were observed, with 500 equiv of building block and 1000 equiv of CsOH as the optimal amount within practical solubility limits (entries 13--15, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

Previous studies into PEPPSI-type catalysts have shown coupling yields can significantly be affected by the degree of substitution at the ortho positions of the NHC phenyl groups and the electron density at the palladium center, particularly when applied to challenging coupling partners.^[@ref54]^ To assess these effects we investigated the coupling of two *m*-bromobenzamide substrates **1** and **2** with aniline under our optimized conditions (entry 15, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) with a variety of differentially substituted PEPPSI-type catalysts ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Commercially available PEPPSI catalysts Pd-PEPPSI-iPr, Pd-PEPPSI-SIPr, Pd-PEPPSI-iPent, and Pd-PEPPSI-iHept---a series that features increasingly bulky ortho positions on a simple NHC backbone---all failed to provide any of the cross-coupled product (entries 1--4, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Surprisingly, even dichlorinated NHC analog Pd-PEPPSI-iPr^Cl^ was not able to provide any product; only the combination of high steric bulk and backbone chlorination in catalyst Pd-PEPPSI-iPent^Cl^ could promote the cross-coupling within this system. Substitution effects at the labile pyridyl ligand could affect the initiation rate and ultimate success of the coupling, and PEPPSI complexes with various pyridine ligands have been reported.^[@ref52]^ However, no significant difference was seen upon switching 3-chloropyridine to 2-picoline or unsubstituted pyridine (entries 6--8, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Finally, increasing the ortho substitution from *i*-pentyl to *i*-heptyl within this chlorinated NHC series did not improve the conversion, and the catalyst suffered from increased initial insolubility (entry 9, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Ultimately, Pd-PEPPSI-iPent^Cl^-pyr was chosen as the optimal catalyst to progress to further studies due to its high reactivity and as it does not produce halogenated pyridyl byproducts that might be capable of oxidative addition.

###### Investigation of PEPPSI Catalysts[a](#t3fn1){ref-type="table-fn"}
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  entry   NHC catalyst                       R^1^       R^2^                                X    Y    **1a**   **2a**
  ------- ---------------------------------- ---------- ----------------------------------- ---- ---- -------- --------
  1       Pd-PEPPSI-iPr                      *i*-Pr     H                                   H    Cl   0%       0%
  2       Pd-PEPPSI-iPent                    *i*-Pent   H                                   H    Cl   0%       0%
  3       Pd-PEPPSI-iHept                    *i*-Hept   H                                   H    Cl   0%       0%
  4       Pd-PEPPSI-SIPr                     *i*-Pr     H[b](#t3fn2){ref-type="table-fn"}   H    Cl   0%       0%
  5       Pd-PEPPSI-iPr^Cl^                  *i*-Pr     Cl                                  H    Cl   0%       0%
  6       Pd-PEPPSI-iPent^Cl^                *i*-Pent   Cl                                  H    Cl   80%      92%
  7       Pd-PEPPSI-iPent^Cl^-*o*-picoline   *i*-Pent   Cl                                  Me   H    69%      91%
  8       Pd-PEPPSI-iPent^Cl^-pyr            *i*-Pent   Cl                                  H    H    78%      91%
  9       Pd-PEPPSI-iHept^Cl^                *i*-Hept   Cl                                  H    Cl   80%      90%

The conversion was determined by LC-MS.

Pd-PEPPSI-SIPr has a saturated NHC ring.

With an optimized catalyst and reaction condition in hand, we next turned to exploring the substrate scope of a set of 10 representative amino nucleophiles on (hetero)aryl electrophiles attached to 17-bp dsDNA constructs ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). In general, good to excellent conversions were observed with simple aromatic amines such as aniline **a**, 3-methoxyaniline **b**, 2-aminopyridine **c**, 2-trifluoromethylaniline **f**, or carboxylated aniline **g** with a variety of halide-coupling partners. Notably, similar results were obtained for these amines with privileged 4-iodo, -bromo, and -chloro benzamide congeners **4**--**6**. However, more challenging aromatic amines, such as *N*-methyl aniline **d** and 3-methyl-5-nitroaniline **e**, suffered from lowered conversions. The presence of nearby coordinating functionality may influence reaction success; although *meta*- and *para*-bromo benzamide **2** and **4** underwent efficient coupling, *ortho*-bromo **3** universally failed to provide coupled products, presumably due to the formation of an intramolecular palladacycle-type interaction.^[@ref55]^ Although a nearby basic amine did not affect the coupling (e.g., **9** vs **10**), the presence of an *ortho*-nitro group in bromide **11** diminished its conversions. We next looked to evaluate these substrates on more challenging cyclic, secondary aliphatic amines with phenyl amine **h**, *N*-Boc diamine **i**, and amino acid **j** chosen as representative examples. Reduced conversions were generally observed utilizing this amine class, particularly in the case of negatively charged amine **j**. Despite this, many substrate combinations coupled in synthetically useful conversion, suggesting that use of these conditions with cyclic secondary aliphatic amines could be a tractable DECL synthetic process. Unfortunately, extension of these conditions to the coupling of acyclic secondary aliphatic amines and primary aliphatic amines with (hetero)aromatic iodides, bromides, and chlorides generally provided the coupled products in low conversion. These results may stem from an enhanced ability of these amines to initiate β-hydride transfer processes and may require further optimization of this catalyst system. Representative results for these type of aliphatic amines, as well as indoles, are presented in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00863/suppl_file/bc9b00863_si_001.pdf).

###### C--N Coupling between Phenyl Halides and Various Anilines and Secondary Amines[a](#t4fn1){ref-type="table-fn"}
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![](bc9b00863_0010){#gr6}

Conversion determined by LC-MS.

No desired product was observed.

The product was observed as a 1:1 ratio of reduced to unreduced nitro group.

All components were observed with a fully reduced nitro group.

To further evaluate these conditions for DECL production, we prepared an expanded set of heterocyclic bromides and chlorides (selected examples, [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). Effects from small changes could be observed, for example, the oxygenation added to **13** relative to nicotinate bromide **12** lowered conversions for anilines **a**--**g** and completely suppressed coupling to aliphatic amines **h** and **i**. Although indole **14** and azole **15** were satisfactory substrates, complex heterocyclic bromides **16**--**19** could not form C--N coupling products in synthetically useful conversions. Heterocyclic chlorides represent a particularly valuable class of substrates to leverage for diverse bifunctional building blocks from historical collections. Fortunately, extension to complex heterocyclic chlorides was fruitful as acyl-functionalized chlorides **20**--**22**, and electron-deficient chlorides **23**--**25** generally provided the desired C--N products in good to excellent yields. Additionally, some heterocyclic substrates prepared within this set failed to provide any C--N products with a variety of amine partners, which may derive from the presence of metal coordination motifs (selected examples, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Taken together, these results highlight the need to evaluate building block sets against representative coupling partner panels to inform building block input and keep C--N coupling DECL productions within desired conversion ranges.

###### C--N Coupling Screening on Various Heteroaryl Bromides[a](#t5fn1){ref-type="table-fn"}
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Conversion determined by LC-MS.

Mostly dehalogenation or addition of dimethylamine was observed.

![Examples of halide substrates that failed to give any desired C--N coupling products.](bc9b00863_0001){#fig1}

To assess the effect of DNA length on the outcome of a late-stage C--N coupling during a DECL production, we prepared 56-bp DNA substrate **31** from **4** via the ligation of two 39-mer oligonucleotides. Application of our optimized Pd-PEPPSI-iPent^Cl^-pyr system to substrate **31** successfully provided biphenyl amine **32** in comparable conversion, and **32** subsequently underwent efficient DNA ligation ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00863/suppl_file/bc9b00863_si_001.pdf) for reaction, LC-MS and gel electrophoresis details). With a library-relevant C--N coupling condition in hand, we sought to assess amine substitution effects across a diverse collection of ∼300 aromatic amines and 92 cyclic secondary aliphatic amines against two representative DNA-conjugated substrates, 4-bromo benzoate **4**, and 5-bromo nicotinate **12** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00863/suppl_file/bc9b00863_si_001.pdf) for a full list of building block structures and coupling results). Although this amine set had not been filtered for reaction compatibility, a majority of screened (hetero)aromatic amines coupled in \>50% conversion for both substrates and many cyclic secondary aliphatic amines coupled in good conversion. Selected examples showing the tolerance for heterocyclic cores as well as distal nitro, cyano, or sulfonamide substitution are shown (**3k**--**3p**, **12k**--**12p**, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Notably, a variety of aromatic amines with distal carboxyl substitution were well tolerated (**3q**--**3t**, **12q**--**12t**, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), potentially a versatile source of bifunctional building blocks for DECL productions. Separately, a variety of piperadinyl, pyrrolidinyl, and piperazinyl building blocks coupled in good to excellent conversions (**3u--3bb, 12u--12bb**, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), although cyclic secondary amines with α-substitution often did not couple significantly. (Hetero)aromatic amines featuring iodide, bromide, or chloride substitution generally failed, presumably due to competing oxidative addition to the building block. In addition, amines that featured a proximal coordinating group generally suffered lowered conversion that was separate from electronic effects (**3cc**/**12cc** vs **3dd**/**12dd** or **3ee** vs **3ff**, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), and coupled products with amines containing a phenolic anion were generally not observed (**3gg**, **3hh**, **12gg**, **12hh**, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).

![DNA Stability and Ligation Test](bc9b00863_0005){#sch2}

![Amine validation with **4** and **12**. (A) Summary of aniline validation with **4**. (B) Summary of aniline validation with **12**. (C) Summary of secondary amine validation with **4**. (D) Summary of secondary amine validation with **12**. (E) Validation results of selected anilines and secondary amines. (F) Representative comparison of the effect from neighboring group.](bc9b00863_0002){#fig2}

After determining the scope of this amination, we sought to further evaluate our C--N coupling conditions through the synthesis of a test-scale, three-cycle "split-and-pool" DECL. This type of DECL consists of iterative cycles of splitting a single or preassembled collection of DNA-appended substrates into individual wells, the attachment of a unique building block, and the concurrent ligation of a unique encoding DNA segment within each well and then a global pooling of all wells.

Thus, three-cycle DECLs with hundreds to thousands of compounds per cycle may produce collections of millions of compounds for screening efforts. In this DECL ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), a series of *N*-protected bifunctional amines was incorporated in cycle 1, and after an *N*-deprotection, a collection of bifunctional cores containing a (hetero)aryl iodide, bromide, or chloride was attached through nucleophilic substitution, reductive amination, or acylation in cycle 2. In cycle 3, a collection of approximately 500 (hetero)aromatic and cyclic secondary aliphatic amines was attached through C--N coupling to provide a DECL of ∼63 million compounds. Postcycle 3 recovery was satisfactory (estimated 72% recovery), and a "naïve" sample of the library (i.e., a DECL sample that has not been subjected to target-based affinity screens) exhibited normal PCR amplification consistent to other DECLs of identical DNA architecture. After sequencing of the naïve DECL sample, all expected sequences were detected within narrow, Gaussian-like distributions, altogether suggesting a limited degradation or imbalance of DNA-encoding segments during the DECL production. In addition, analysis of the percentage of perfect sequences observed during naïve sequencing was close to our historical average observed over dozens of libraries (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00863/suppl_file/bc9b00863_si_001.pdf) for DECL synthesis, sequencing details, and sequencing analysis).

![Use of the developed C--N coupling condition in a three-cycle DECL.](bc9b00863_0003){#fig3}

Conclusions {#sec3}
===========

In conclusion, we developed a mild and general C--N condition that may be applied to DNA-conjugated (hetero)aryl iodides, bromides, and chlorides with (hetero)aromatic amines and cyclic secondary aliphatic amines in good to excellent conversions with negligible DNA decomposition. Within this study, we investigated the substitution needed within the PEPPSI catalyst series and additives required to promote effective coupling, demonstrated the broad substrate scope, and further validated the condition within the synthesis and subsequent use within a DECL. This report builds upon the work of others by extending DNA-compatible C--N coupling to chloride substrates, which should enable the synthesis of more diverse DECLs by expanding the available sourcing of (hetero)aryl electrophiles within current building block collections. However, further work is needed to extend this class of palladium catalysts broadly to the coupling of primary aliphatic amines and acyclic secondary aliphatic amines. Catalyst modifications designed to increase the catalyst room-temperature solubility in mixed aqueous solvent as well as alter the initiation mechanism may improve catalyst performance and are currently underway.

Experimental Procedures {#sec4}
=======================

Materials and Instrumentation {#sec4.1}
-----------------------------

The central dsDNA oligonucleotides with chemically modified phosphates that end in an amine terminus and encoding 5′-phosphorylated oligonucleotides were purchased from LGC Biosearch Technologies. All DNA oligonucleotides were assessed through the general analytical procedure for purity. DNA sequences were designed to maximize sequence reads and minimize close similarity while sequencing. DNA oligomers in each codon-duplexed pair were designed to feature a divergent mass greater than 5 Da for efficient quality control analysis. A 10-mer DNA oligomer (spike-in), featuring a cholesterol tag and amine terminus, was obtained from Sigma-Aldrich and charged in a library pool to monitor chemical reactions. High-concentration T4 DNA ligase was obtained from Enzymatics (Qiagen). The oligomer ligation test with DTSU was incorporated to determine the ligase activity before use. DNA working solutions were prepared using DNase/RNase-free ultrapure water (Invitrogen), HPLC-grade acetonitrile (Fisher), or high-purity absolute ethanol (Koptec). LC/MS running solvents were made from Optima LC/MS-grade water (Fisher), Optima LC/MS-grade methanol (Fisher), hexafluoroisopropanol (99+% purity, Sigma-Aldrich), and HPLC-grade triethylamine (Fisher). All listed buffers and ionic solutions, including HEPES 10× ligation buffer (300 mM 2-\[4-(2-hydroxyethyl)piperazin-1-yl\]ethanesulfonic acid, 100 mM MgCl~2~, 100 mM dithiothreitol, 10 mM adenosine triphosphate, pH 7.8), aq. NaOH, aq. NaCl (5 M), and basic borate buffer (250 mM sodium borate/boric acid, pH 9.5), were prepared in house. Chemical building blocks and reagents were purchased from various vendor sources and used without further purification. Building blocks were generally used from aliquots dissolved in acetonitrile (MeCN), methoxyisopropanol (MIPO), dimethylacetamide (DMA), or mixed aqueous acetonitrile and stored in 2D barcoded tubes (Phenix) with septacaps at −80 °C. Barcoded tubes were read using a SampleScan 96 scanner (BiomicroLab) and decoded using Vortex software (Dotmatics). Solutions were transferred utilizing Biotix brand or Fisher brand pipet tips and Biotix reservoirs. Reactions and library transformations were generally performed in polypropylene PCR tubes (Genemate), polypropylene tubes (Eppendorf), 96-well polypropylene PCR plates (Phenix or ThermoFisher), or 96-well, deep-well plates (USA Scientific). Plates were sealed for incubation with AlumaSeal II sealing films (Excel Scientific), and large-volume DNA precipitations were performed in polypropylene 250 mL screw-cap bottles (various vendors) or centrifuge tubes. Heated reactions were performed in benchtop heating blocks (ThermoFisher), Mastercycler nexus gradient (Eppendorf), a TS-DW deep-well plate themoshaker (Grant), or laboratory ovens (Fisher). Solutions were centrifuged in 5424R centrifuges (Eppendorf), Allegra X-15R centrifuges (Beckman-Coulter), or Lynx 4000 centrifuges (ThermoFisher). Optical density measurements were made using a Biophotometer (Eppendorf). A Vanquish UHPLC system was integrated with a LTQ XL ion trap mass spectrometer (ThermoFisher Scientific) for LC/MS analysis of oligonucleotides. DNA was visualized with a Molecular Imager Gel Doc XR system (BIO-RAD) after staining in an ethidium bromide solution.

Data Analysis {#sec4.2}
-------------

Samples were analyzed on a Thermo Vanquish UHPLC system coupled to an electrospray LTQ ion trap mass spectrometer. An oligonucleotide column (Thermo DNAPac RP, 2.1 × 50 mm, 4 μm) was equipped with ion-pairing mobile phase (15 mM TEA/100 mM HFIP in a water/methanol solvent system) for all of the separations. All mass spectra were acquired in the full scan negative-ion mode over the *m*/*z* range of 500--2000. Data analysis was performed by exporting the raw instrument data (.RAW) to an automated biomolecule deconvolution and reporting software (ProMass) which uses a novel algorithm (ZNova) to produce artifact-free mass spectra. Deconvoluted mass spectra were standardized against cocurrently run samples of DNA standards to account for any drift from theoretical mass during deconvolution.

Ethanol Precipitation and DNA Reconstitution {#sec4.3}
--------------------------------------------

To a DNA reaction aqueous mixture was added 4% (v/v) 5 M NaCl solution and 3 times of the reaction volume of absolute ethanol. The mixture was mixed thoroughly before being stored at −20 °C overnight for DNA precipitation. The slurry was then centrifuged at 4000*g* for 1 h, followed by decanting the supernatant. The pellet was washed with 75% chilled ethanol, and the pellet was centrifuged at 4000*g* for another hour. The DNA pellet was dried in air after the supernatant was decanted. Water was added to reconstitute the DNA to the needed concentration. Ethanol precipitation was generally performed after each chemical reaction and ligation. Additional ethanol precipitation can be applied if residual reagent was observed after the first purification. Dilution with 2--4 times the reaction volume of water may be added before purification, while a higher percentage of water-miscible solvent was used, such as DMSO.

General Procedure for DNA-Compatible PEPPSI C--N Coupling {#sec4.4}
---------------------------------------------------------

To a solution of DNA-conjugated aryl halide substrate (10 μL, 10 nmol, 1.0 mM in water) was added DMA (3.5 μL), 1000 equiv of CsOH (5 μL, 2000 mM in water), 500 equiv of amines (12.5 μL, 400 mM in DMA), and 20 equiv of freshly prepared sodium ascorbate (5 μL, 40 mM in water). The mixture was thoroughly mixed before adding 2 equiv of freshly prepared Pd-PEPPSI-iPent^Cl^-pyr (4 μL, 5 mM in DMA). The reaction mixture was heated at 95 °C for 15 min, followed by addition of 100 equiv of the scavenger sodium [l]{.smallcaps}-cysteine (5 μL, 200 mM in water) and then heating at 80 °C for another 15 min. The mixture was then cooled to room temperature before assessing with LC-MS or purification by EtOH precipitation. PEPPSI catalysts used in this study were synthesized via known procedures and/or purchased from either Total Synthesis Ltd. or Sigma-Aldrich and used without further purification. While conducting a subsequent ligation, insurance of maximum removal of residual building blocks or salts before ligation was necessary as a large amount of residue may influence the ligation efficiency.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acs.bioconjchem.9b00863](https://pubs.acs.org/doi/10.1021/acs.bioconjchem.9b00863?goto=supporting-info).Details of experimental procedures, DNA structures, DECL construction, and selection experiments ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00863/suppl_file/bc9b00863_si_001.pdf))
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